title: Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.
authors.forename: Fabian
authors.initials: F
authors.lastname: Klostermann
authors.forename: Constanze
authors.initials: C
authors.lastname: Jugel
authors.forename: Miriam
authors.initials: M
authors.lastname: Bömelburg
authors.forename: Frank
authors.initials: F
authors.lastname: Marzinzik
authors.forename: Georg
authors.initials: G
authors.lastname: Ebersbach
authors.forename: Thomas
authors.initials: T
authors.lastname: Müller
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D002230:Carbidopa / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006801:Humans; D007263:Infusions, Parenteral; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy
chemical_list: D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa